THRIVE-132: Therapy for Reduction in VOC Readmissions with Inclacumab
To identify treatments that do not rely only on opioids or other medications. Participants will use their smartphone to answer questionnaires and interact with a mobile application
18 to 28
Survey
test
Phase 2
Hb SC
Hb Sβ0 thalassemia
Hb Sβ+ thalassemia
....
United States
Turkey
Canada
Sickle Cell and the COVID-19 Vaccine
Sickle Cell 101 is conducting a study on the attitudes and impacts of the COVID-19 vaccine in the sickle cell community.
Online survey
Raffle
All genotypes
Global
Venous Thrombosis Biomarkers in SCD and SCT
To study blood clotting in SCD because it is the most common cause of vascular death after a heart attack or stroke. To study blood clotting in SCD because it is the most common ca
Survey
No
Hb SS
Hb SC
United States
08 Jul 2021
CTX001 is being investigated in two ongoing Phase 1/2 clinical trials as a potential one-time therapy for patients suffering from transfusion-dependent beta thalassemia (TDT) and severe sickle cell disease (SCD). In total, more than 40 patients have been dosed across both studies to date. All 15 patients with TDT, including six who have the beta […]
Learn more
06 Jul 2021
Patients with sickle cell disease (SCD) have vaso-occlusive crises (VOCs). Infusion centers (ICs) are alternatives to emergency department (ED) care and may improve patient outcomes.
Learn more
23 Jun 2021
The American Red Cross says we are in the midst of a severe blood donation shortage. “People with sickle cell disease depend on blood transfusions regularly.”
Learn moreWe send occasional updates that feature new trials, and other great tips. We will not spam you.
